Risks and benefits
Sections
Potential side effects
Ketamine is not a licensed treatment for depression and the effects of taking it long term are unknown. There may also be unusual side-effects which occur acutely which have not yet been reported.
About 10% of people who have a ketamine infusion have an experience that is very challenging. If you find any of the side effects too unpleasant then these will almost always resolve within 15 minutes of stopping the infusion. Occasionally people experience a worsening in their depressive symptoms and suicidality which persists for up to two weeks after taking ketamine. Sometimes this is sufficiently unpleasant that they do not want to take further ketamine. Those who do persist with further treatment often find that it starts to help after 1-2 more infusions.
Of the remaining 90%, about half have a very pleasant experience and in the remainder it is neither unpleasant nor pleasant.
Benefits
Ketamine is a treatment for depression which has not responded to other treatments. A rapid antidepressant effect has been demonstrated in many clinical trials of single intravenous infusions over the last 20 years in patients with depression which has not responded to at least 2 or 3 antidepressants.
The response lasts at least a day for about 70% of patients and up to three days for 30% of patients. The majority of patients relapse within two weeks after treatment.
In our clinic 50% of people who try ketamine have enough of a benefit that they think it is worth continuing with it.
It is important to recognise that ketamine is not licensed as an antidepressant. It has not been evaluated in large, or long term, clinical trials. This means that the long-term success rates have not been fully documented.
Large trials of the closely related drug esketamine, which is a component of ketamine, have shown broadly similar effects. A safety study of over 800 patients who took intranasal esketamine and a newly initiated antidepressant showed a 43% remission rate after 12 months of treatment. Remission is when there are no longer any significant symptoms of depression. For comparison, a large randomised study of people with depression found that those whose depression had not responded adequately to two previous antidepressants had a 5% chance of being in remission 12 months later if they tried a third antidepressant.
Non-urgent advice: Downloadable information
This PDF contains all the text on the website, used for consent.
Page last reviewed: 5 March, 2024